MIM
EPZM

MetLife Investment Management’s Epizyme, Inc EPZM Stock Holding History

MetLife Investment Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-6,462
Closed -$16.2K – 2790
2021
Q4 		$16.2K Sell
6,462
-26,366
-80% -$104K ﹤0.01% 2488
2021
Q3 		$168K Buy
32,828
+9,327
+40% +$56.6K ﹤0.01% 2194
2021
Q2 		$195K Sell
23,501
-12,347
-34% -$104K ﹤0.01% 2188
2021
Q1 		$312K Buy
35,848
+4,350
+14% +$45K ﹤0.01% 1792
2020
Q4 		$342K Sell
31,498
-8,472
-21% -$105K ﹤0.01% 1684
2020
Q3 		$477K Sell
39,970
-9,258
-19% -$124K 0.01% 1390
2020
Q2 		$791K Buy
49,228
+16,843
+52% +$294K 0.01% 1124
2020
Q1 		$502K Sell
32,385
-3,837
-11% -$82.4K 0.01% 1214
2019
Q4 		$891K Hold
36,222
– – 0.01% 1150
2019
Q3 		$374K Sell
36,222
-10,574
-23% -$133K ﹤0.01% 1571
2019
Q2 		$587K Sell
46,796
-28,429
-38% -$366K 0.01% 1382
2019
Q1 		$932K Buy
75,225
+50,150
+200% +$561K ﹤0.01% 1699
2018
Q4 		$154K Hold
25,075
– – ﹤0.01% 2056
2018
Q3 		$266K Hold
25,075
– – ﹤0.01% 1928
2018
Q2 		$340K Buy
25,075
+4,155
+20% +$64.7K ﹤0.01% 1645
2018
Q1 		$371K Hold
20,920
– – ﹤0.01% 1556
2017
Q4 		$263K Buy
+20,920
New +$304K ﹤0.01% 1774

Other funds holding EPZM

RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MetLife Investment Management's EPZM Position: Q1 2022 in Review

MetLife Investment Management sold out of Epizyme, Inc (EPZM) in Q1 2022, closing a stake of 6,462 shares — an estimated $16.2K sold.

MetLife Investment Management first reported a position in EPZM in Q4 2017 and held it in 17 quarters. The position peaked at $932K in Q1 2019. 120 funds tracked by Wall St. Rank hold EPZM as of Q1 2022.

  • MetLife Investment Management reported no remaining Epizyme, Inc position as of Q1 2022 after selling out during the quarter.
  • MetLife Investment Management sold 6,462 Epizyme, Inc shares in Q1 2022, an estimated $16.2K.
  • MetLife Investment Management first reported a position in Epizyme, Inc in Q4 2017 and held it in 17 quarters.
  • MetLife Investment Management's Epizyme, Inc position peaked at $932K in Q1 2019.
  • 120 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2022.

Based on MetLife Investment Management's 13F filing for Q1 2022, filed 12 May 2022.